Herbert Irving Comprehensive Cancer Center Columbia University Medical Center is a clinical research site located in New York, New York, United States 10032.
Crixeo Health Trust Score: 70/100 (FAIR). This profile has not yet been claimed by the site owner.
Herbert Irving Comprehensive Cancer Center Columbia University Medical Center has participated in 8 clinical trials with 7 currently active.
Therapeutic areas: Colorectal Neoplasms, Carcinoma, Non-small-Cell Lung, Relapsed or Refractory Multiple Myeloma.
Sponsors: Janssen Research & Development, LLC, Johnson & Johnson Enterprise Innovation Inc..
Trust Score: 70/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Herbert Irving Comprehensive Cancer Center Columbia University Medical Center has a Crixeo Trust Score of 70/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Herbert Irving Comprehensive Cancer Center Columbia University Medical Center has 8 clinical trials on record, with 7 currently active. Their work covers Colorectal Neoplasms, Carcinoma, Non-small-Cell Lung, Relapsed or Refractory Multiple Myeloma.
Yes — Herbert Irving Comprehensive Cancer Center Columbia University Medical Center holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.